Synergistic enhancement: Exploring the potential of piperine in cancer therapeutics through chemosensitization and combination therapies

MK Manickasamy, A Kumar, B BharathwajChetty… - Life Sciences, 2024 - Elsevier
Despite significant advancements in chemotherapy, effective treatments for advanced
cancer stages remain largely elusive due to chemoresistance. Resistance to anticancer …

Molecular mechanisms of Hippo pathway in tumorigenesis: therapeutic implications

MJ Saadh, HH Ahmed, RA Kareem, AK Bishoyi… - Molecular Biology …, 2025 - Springer
The Hippo signaling pathway is a pivotal regulator of tissue homeostasis, organ size, and
cell proliferation. Its dysregulation is profoundly implicated in various forms of cancer …

LPA released from dying cancer cells after chemotherapy inactivates Hippo signaling and promotes pancreatic cancer cell repopulation

Y Liu, J Ding, S Li, A Jiang, Z Chen, M Quan - Cellular Oncology, 2025 - Springer
Abstract Purpose The Hippo pathway in the tumorigenesis and progression of PDAC, with
lysophosphatidic acid (LPA) regulating the Hippo pathway to facilitate cancer progression …

Transient activation of YAP/TAZ confers resistance to morusin-induced apoptosis

H Lee, SW Cho, HS Cha, K Tae, CY Choi - BMC Molecular and Cell …, 2025 - Springer
Abstract Background The Hippo signaling pathway involves a kinase cascade that controls
phosphorylation of the effector proteins YAP and TAZ, leading to regulation of cell growth …

YAP1 Overexpression Enhances the Aerobic Glycolysis Process via Suppression of EGLN2 in Pancreatic Ductal Adenocarcinoma

P Hu, R Dou, Z Qi, G Liu, Y Su - The Journal of Gene Medicine, 2024 - Wiley Online Library
Background Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive
diseases and has remarkably high mortality rates. In recent years, altered metabolism has …

LPA released from dying cancer cells after chemotherapy inactivates Hippo signaling and promotes pancreatic cancer cell repopulation

L Yuzhi, D Jie, L Shumin, A Jiang, Z Chen, M Quan - 2024 - researchsquare.com
Gemcitabine-based chemotherapy remains the cornerstone of comprehensive treatment for
pancreatic ductal adenocarcinoma (PDAC). A significant bottleneck in tumor therapeutic …